Webinars

Michael Bauer is head of the Department of Anaesthesiology and Intensive Care Medicine at the Jena University Hospital, Germany. His research focuses on basic, translational and clinical research in infection-associated organ dysfunction and theranostic strategies to restore organ function. This includes the development of diagnostic tools for the assessment of life-threatening infections, the development of theranostic approaches enabling individualized treatment strategies, and clinical management.

Evangelos J. Giamarellos-Bourboulis is Professor of Internal Medicine and Infectious Diseases at the Medical School of the National and Kapodistrian University of Athens and director of the MSc program of Infectious Diseases at the University of Athens. His main research contribution is immunomodulation in sepsis and in auto-inflammatory disorders. He has 606 publications in international peer-reviewed journals with more than 46,000 citations and h-index 99. He has contributed in the development of clarithromycin for immunomodulatory treatment of severe infections; and in the recognition of hidradenitis suppurativa (HS) as an auto-inflammatory disorder and in the licensing of adalimumab for HS treatment. He is the current chairman of the European Sepsis Alliance and the current President of the Hellenic Society of Chemotherapy. His main achievement is the approval of anakinra for COVID-19 pneumonia in adults by the European Medicines Agency and the Food and Drug Administration through the phase 2 and 3 trials SAVE and SAVE-MORE that he designed and conducted.

Bram Rochwerg is an intensivist and researcher based at McMaster University in Hamilton, Canada. He leads multi-national randomized controlled trials in sepsis and acute hypoxemic respiratory failure. He is chair for the Internal Medicine Section at the Society of Critical Care Medicine and chair-elect for The Canadian Critical Care Trials Group. He is vice-chair for the international Surviving Sepsis Campaign, an Associate Editor at Critical Care Medicine and ACP Journal Club and serves on the editorial board at CHEST. In addition to this, he supports many national and international societies in developing clinical practice guidelines in the field of critical care.

Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK.  His major research interests include basic, translational and clinical research studies in sepsis. He co-chaired the 'Sepsis-3' Definitions International Task Force and was one of the leads for SOFA-2. He is the Sepsis Topic Adviser to NICE, past-Chair of the International Sepsis Forum and an Emeritus UK NIHR Senior Investigator.

Margaret Herridge is a Professor in the Department of Medicine, a Senior Scientist at the Toronto General Hospital Research Institute, and a member of the University of Toronto Interdepartmental Division of Critical Care Medicine. She serves as the Director of the national RECOVER ICU Care Continuum Program, funded by the Canadian Institutes of Health Research (CIHR), as well as the Grace RECOVER Program for chronic critical illness. Additionally, she is the co-Lead of CANCOV (a Canadian multicenter 5-year follow-up study of COVID-19 patients and their caregivers) and is internationally recognized as an expert on long-term clinical outcomes for critical illness survivors and their family caregivers. She holds a Tier 1 Canada Research Chair in Critical Illness Outcomes and the Recovery Continuum.

Julian Knight is a Professor of Genomic Medicine at the University of Oxford and an Honorary Consultant Physician within the Oxford University Hospitals NHS Foundation Trust (UK). He is a Principal Investigator at the Wellcome Centre for Human Genetics, where he leads research on the genomics of the immune system and how our genetic traits influence individual responses to infection, particularly sepsis. Alongside his research activities, he practices internal medicine and is a Fellow of the Academy of Medical Sciences. His work aims to integrate genomic medicine into clinical practice by combining research, education, and the development of novel medical approaches.

Tom van der Poll is a Professor of Medicine and Chair of the Department of Medicine at the Amsterdam University Medical Center (Netherlands). He is a board-certified specialist in internal medicine and infectious diseases. His research focuses primarily on pneumonia and sepsis, particularly on disease pathogenesis, the host response to infection, immunotherapy, and biomarkers. He has published over 1,000 scientific papers in this field. He is a former chair of the International Sepsis Forum and served on the international committee that established the current sepsis definitions, published in JAMA in 2016. He was elected as a member of the Royal Netherlands Academy of Arts and Sciences in 2019 and of Academia Europaea in 2023.

Manu Shankar-Hari is a Professor of Translational Critical Care Medicine at the University of Edinburgh and practices as a Consultant Physician in Critical Care Medicine. His academic and scientific background combines two core disciplines: a Master's degree in Epidemiology and a PhD in Immunology. His research in translational immunology spans the entire spectrum from bench to bedside, aiming to better understand immune system dysfunction and to develop immunomodulation strategies for critically ill patients. He leads a research laboratory dedicated to addressing one of the greatest challenges in global medicine: sepsis.